Journal
EUROPEAN RESPIRATORY JOURNAL
Volume 43, Issue 2, Pages 523-530Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00027613
Keywords
-
Categories
Funding
- American Heart Association [11FTF7400032]
- ASPIRE Pulmonary Vascular Disease Young Investigator Research Award [WS1952812]
- National Institutes of Health [K24 HL103844]
Ask authors/readers for more resources
Female sex is a risk factor for pulmonary arterial hypertension (PAR), yet females have better survival than males. We sought to determine if sex was associated with baseline haemodynamics in subjects with PAH, and whether age modified these relationships. We conducted a pooled analysis from 11 randomised trials submitted to the US Food and Drug Administration. The study sample included 1211 subjects with idiopathic PAR, 25% of whom were males, and 489 subjects with connective tissue disease-associated PAR, 13% of whom were males. After multivariable adjustment, right atrial pressure was 1.36 mmHg higher (95% CI 0.44-2.27, p=0.004), cardiac index was -0.14 L.min(-1).m(-2) lower (95% CI-0.23-0.04, p=0.01) and pulmonary vascular resistance was 1.23 Wood units higher (95% CI 0.18-2.27, p=0.02) in males compared with females. Younger males had 5.43 mmHg (95% CI 2.20-8.66, p0=0.001) higher mean pulmonary arterial pressures than younger females, but these relationships were attenuated after age 45 years. In the subgroup of connective tissue disease-associated PAR, males may have had higher right atrial pressure. These findings implicate age as a modifier and provide further evidence of sexual dimorphism in PAH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available